kinetin has been researched along with alpha-synuclein in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Roulet, D; Hertz, NT; Huang, EJ; Nakamura, K; Orr, AL; Rutaganira, FU; Shokat, KM | 1 |
1 other study(ies) available for kinetin and alpha-synuclein
Article | Year |
---|---|
Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
Topics: Administration, Oral; alpha-Synuclein; Animals; Cells, Cultured; Disease Models, Animal; Drug Administration Schedule; Humans; Kinetin; Male; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Parkinson Disease; Protein Kinases; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Rodentia | 2017 |